REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPURE.L Regulatory News (PURE)

  • There is currently no data for PURE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

16 Mar 2015 07:00

RNS Number : 4720H
PureCircle Limited
16 March 2015
 



PureCircle Limited

("PureCircle" or the "Company")

Interim results for the six months ended 31 December 2014

PureCircle (LSE: PURE) the world's largest producer and marketer of high purity stevia today announces its unaudited interim results for the six month period from 1 July 2014 to 31 December 2014 ("1H FY 15").

 

The unaudited financial statements comprising the profit and loss and cashflow statements for the six months to 31 December 2014 ("1H FY15") along with the balance sheet as at 31 December 2014 are set out below, together with the unaudited profit and loss and cashflow comparatives for the six months to 31 December 2013 ("1H FY14").

 

SUMMARY FINANCIALS

Period ended 31 December (US$m)

1H FY15

1H FY14

Change

Sales

43.2

34.9

24%

Gross margin

14.5

12.3

18%

Operating profit**

3.5

2.9

21%

EBITDA**

6.4

5.2

24%

Net result after tax

(0.9)

(1.9)

53%

Net debt

(52)

(85)

39%

Net assets

188

141

33%

Net assets per share (US cents)

1.1

0.9

29%

 

** Operating profit and EBITDA are as per segmental reporting on page 13. The full profit and loss account is detailed on page 4.

 

 Sales: Sales of $43m increased 24% over 1H FY14 ($35m). There was growth in sales in all of our global sales regions.

Gross margin: Gross margin increased 18% to $14.5m. Gross margin % of 34% was consistent with 1H FY14 (35%).

EBITDA: EBITDA increased 24% in line with sales revenues to $6.4m. EBITDA improvements are after $1.5m increased SG&A investment in PCL's operational management and global customer service infrastructure, including in-region application capacity, to support anticipated future sales growth.

Net Result after Tax: 1H FY15 net result of ($0.9m) represented a $1m (53%) improvement on 1H FY14. The net result reflects $1.2m improved EBITDA, $0.6m increased Long Term Incentive Plan (LTIP) costs, $3m adverse foreign exchange movements and $3.8m favourable interest and tax.

Net debt: Net debt of $52m is $33m lower than the $85m at 31 December 2013. This reflects $43m November 2014 placement proceeds, offset by increases in inventory production ahead of anticipated H2 and FY16 sales growth.

During 1H FY15 the Group successfully restructured its principal bank facilities. $20m of debt was repaid a year early and the balance refinanced onto a new $71m 5 year facility (to September 2019) at a 3% lower interest rate. 

Share Placement: In November 2014 the Group issued 5 million new ordinary shares at GBP 5.50 per share raising $43m to fund expansion of its production capacity, described in more detail below.

 

Interim results for the six months ended 31 December 2014 (continued)

 

BUSINESS DEVELOPMENTS

 

Market: Since the end of FY14 the Stevia market has seen an unparalleled series of milestone F&B product launches and roll-outs integrating stevia into mainstream products. High profile Cola roll-outs led by Coca-Cola Life, Pepsi Next and Pepsi True into major markets like the USA, Mexico, UK, France, Japan and other markets and reformulations across a range of leading carbonated Lemon Lime, Orange and other brands indicate clearly that stevia is now seen as a mainstream sweetener of choice in the Carbonated Soft Drink (CSD) category. The period has also seen a wide range of stevia sweetened product launches from major retailers across Europe and America and iconic brand adoption in categories as diverse as Ketchups, Yogurts and Confectionery.

 

Global brand adoption has been mirrored with growth in product launches by large regional F&B brands across the world: from Chile in the South to Finland in the North and from Japan, China, and Philippines in the East to Mexico in the West. Mintel reports 2,274 new product launches in 2014 taking 5 year launches over 6,000. Mintel report that food product adoption exceeded beverages by number, confirming the widening usage of stevia as a mainstream ingredient. With 4 billion consumers now having regulatory access to stevia, market estimates suggest that the current footprint of products already launched using stevia has the potential to support billion dollar industry when existing launches are rolled out fully across the next 10+ years.

 

Innovation: PureCircle continues to lead stevia innovation with new products and applications designed to meet identified market needs and unlock further demand to help moderate calories naturally. 1H FY15 saw important developments including the successful launch of Sigma D, which has excellent application properties in the dairy sector, and further developments within our proprietary flavor systems. Each of our new developments continue to grow overall market usage and strengthen further our market share.

With our strong diversified customer base, our unique breadth of product innovation and application support and our global supply chain and customer support infrastructure already established PureCircle continues to retain and build further market leadership.

 

Production capacity expansion: With the prospects of sustained long term market growth, PureCircle has started to expand its production capacity so as to meet anticipated future increased volume demand and further sustain market share and its first mover advantage. The PureCircle Board has approved $42m of capital expenditure projects that will increase production capacity of refined stevia sweeteners and natural flavor systems and provide additional investment in next generation stevia innovation.

 

It is expected that $34m of the investment will be for production capacity expansion to come on stream  in FY17 with the balance of $8m supporting innovation projects through FY18. The $42m investment will be funded from the $43m November 2014 Placement proceeds described earlier.

 

The production capacity expansion will be centred on the Group's existing Malaysia and China production facilities.

 

Leaf: with growth in end consumer demand, leaf supply has tightened. Prices in China have increased year on year. We are actively managing this long term through leading the diversification of leaf supply outside China. But in the short term higher leaf prices will increase cost of sales.

 

 

 

Interim results for the six months ended 31 December 2014 (continued)

 

Sustainability: In January PureCircle issued the industry's first sustainability report. The report demonstrates the efficient carbon and water footprint of stevia relative to other major sweeteners and tracks progress against the Company's social and environmental goals. The full report may be downloaded at http://purecircle.com/company/corporate-social-responsibility/

 

Management and systems: To support management of growth, in 1H FY15 we strengthened our management with the appointment of Jordi Ferre as Chief Operating Officer and implemented an Operating Committee reporting to him with key new hires in Manufacturing, Leaf Development, HR and Planning. At the same time we have strengthened management in each of our key Commercial regions. We also implemented the first stages of Group ERP information systems.

 

 

Outlook: Commenting on the 1H FY15 trading, the Group CEO Magomet Malsagov said:  the size and breadth of F&B product launches and roll-outs in 1H FY15 indicate that stevia is well on the way to becoming an important ingredient for F&B companies wishing to moderate calories. Further the existing footprint of products launched using stevia provides a sound basis for a multi-billion $ stevia industry in the years to come.

 

In 1H FY15 we again strengthened our position as market leader with further proprietary product innovation and growth in both delivered sales and project pipelines. With sustained long term growth prospects, PureCircle has started to expand our production capacity and expect this to come on stream in FY17.

 

We are generating revenues from a wide range of natural sweetener and flavor products and from a wide range of customers directly and through our business partners. With accelerating roll-outs of food and beverage products using PureCircle's stevia solutions, particularly in the important Carbonated Soft Drink category, the Company is confident of large long term sales growth and with it improvements in profitability. However, until market consumption smooths out, that growth will come with a lumpy sales profile and therefore some volatility: this adds some complexity to our ability to provide guidance in the short term.

 

 

Magomet Malsagov, CEO

+603 2166 2066

William Mitchell, CFO

+44 7974 005 163

RFC Ambrian Ltd (NOMAD)

+61 8 9480 2500

Stephen Allen

 

NOTES TO EDITORS

PureCircle is the global leader in the production of high purity Stevia sweeteners and natural flavors. PureCircle is leading the industry with the development of a sustainable, vertically integrated supply chain operating in four continents. Across these regions, PureCircle sources dry stevia leaves, undertakes extraction processes and refines the extract into sweeteners which it markets as a mainstream ingredient to Food and Beverage manufacturers worldwide. PureCircle provides a sustainable cash crop for rural farming communities in each region and works closely with these communities to maximize the social, economic, and environmental benefits of its operations. PureCircle's investment in research and development has given it a leadership position in the Stevia industry and its scientists are globally recognized experts in their field. PureCircle has pioneered the industry trust mark "Stevia PureCircle" that educates consumers about the benefits of Stevia and provides a strong base of trust for both consumers and Food & Beverage companies alike. PureCircle also funds the Global Stevia Institute (globalsteviainstitute.com) which provides a global platform for stevia education and outreach, led by internationally recognized health professionals. PureCircle's corporate offices are located in Chicago, USA; Asuncion, Paraguay; Kuala Lumpur, Malaysia; Ganzhou, China; Shanghai, China and Kericho, Kenya. PureCircle is listed on the London Stock Exchange AiM market under the ticker symbol: PURE. For more information on PureCircle, visit: www.purecircle.com.

 

Condensed consolidated statement of comprehensive income

for the period ended 31 December 2014

Unaudited

Notes

Six months ended

31 December

31 December

2014

2013

USD'000

USD'000

Continuing operations

Revenue

43,228

34,851

Cost of sales

(28,435)

(22,596)

Gross profit

14,793

12,255

Other income

6

148

2,057

Other expenses

7

(1,348)

 -

Administrative expenses

(13,693)

(11,782)

Finance income

12

180

Finance costs

(3,768)

(4,537)

Share of loss of joint ventures

(516)

(532)

Loss before taxation

(4,372)

(2,359)

Income tax credit

15

3,445

470

Loss for the period

(927)

(1,889)

Other comprehensive income (net of tax):

Items that may be reclassified subsequently to profit or loss:

Exchange difference arising on translation of foreign

operations

(5,646)

(1,160)

Share of other comprehensive income of investments accounted

for using equity method

(34)

(43)

(5,680)

(1,203)

Total comprehensive loss for the period (net of tax)

(6,607)

(3,092)

Loss for the financial period attributable to:

Owners of the company

(899)

(1,894)

Non-controlling interest

(28)

5

(927)

(1,889)

Total comprehensive loss attributable to:

Owners of the company

(6,590)

(3,106)

Non-controlling interest

(17)

14

(6,607)

(3,092)

Earnings per share (US cents)

Basic

17

(0.54)

(1.15)

Diluted

17

(0.54)

(1.15)

Condensed consolidated statement of financial position

As at 31 December 2014

Unaudited

Audited

31 December

30 June

Notes

2014

2014

 USD'000

USD'000

Assets

Non-current assets

Property, plant and equipment

11

59,651

63,715

Intangible assets

11

37,818

38,023

Biological assets

13

3,990

4,237

Prepaid land lease payments

2,973

2,999

Deferred tax assets

9,282

5,876

Investment in joint ventures

312

149

Trade receivables

-

1,950

Other receivables

1,415

553

115,441

117,502

Current assets

Inventories

12

96,810

86,519

Trade receivables

36,220

37,362

Other receivables and prepayments

7,547

4,962

Tax recoverable

501

581

Cash and bank balances

58,325

45,865

199,403

175,289

Total assets

314,844

292,791

Equity and liabilities

Equity

Share capital

16

16,973

16,472

Share premium

16

206,251

163,240

Foreign exchange translation reserve

(4,771)

920

Share option reserve

7,597

5,076

Accumulated losses

(39,102)

(38,203)

Equity attributable to owners of the company

186,948

147,505

Non-controlling interest

705

722

Total equity

187,653

148,227

Non-current liabilities

Long-term borrowings

14

67,515

2,169

Deferred income

319

360

Other payables and accruals

2,180

2,111

70,014

4,640

Current liabilities

Trade payables

5,799

5,879

Other payables and accruals

9,090

10,364

Short-term borrowings

14

42,288

123,681

57,177

139,924

Total liabilities

127,191

144,564

Total equity and liabilities

314,844

292,791

Net assets per share (USD)

1.11

0.90

Condensed consolidated statement of changes in equity

as at 31 December 2014

Attributable to owners of the Company

Foreign

exchange

Share

Non-

Share

Share

translation

option

Accumulated

controlling

Total

capital

premium

reserve

reserve

losses

Sub-total

interest

equity

USD'000

USD'000

USD'000

USD'000

USD'000

USD'000

USD'000

USD'000

Balance at 1 July 2014

16,472

163,240

920

5,076

(38,203)

147,505

722

148,227

Loss for the period

-

-

-

-

(899)

(899)

(28)

(927)

Other comprehensive income

-

-

(5,691)

-

-

(5,691)

11

(5,680)

Total comprehensive loss for the period (net of tax)

-

-

(5,691)

-

(899)

(6,590)

(17)

(6,607)

Share option scheme compensation expense granted during the period

-

-

-

2,570

-

2,570

-

2,570

Issuance of shares

500

42,963

-

-

-

43,463

-

43,463

Exercise of share options

1

48

(49)

Balance at 31 December 2014

16,973

206,251

(4,771)

7,597

(39,102)

186,948

705

187,653

 

 Condensed Consolidated Statement of Changes in Equity as at 31 December 2013

Attributable to owners of the Company

Foreign

exchange

Share

Non-

Share

Share

translation

option

Accumulated

controlling

Total

capital

premium

reserve

reserve

losses

Sub-total

interest

equity

USD'000

USD'000

USD'000

USD'000

USD'000

USD'000

USD'000

USD'000

Balance at 1 July 2013

16,460

162,898

1,432

1,530

(40,519)

141,801

715

142,516

Loss for the period

-

-

-

-

(1,894)

(1,894)

5

(1,889)

Other comprehensive income

-

-

(1,212)

-

-

(1,212)

9

(1,203)

Total comprehensive loss for the period (net of tax)

-

-

(1,212)

-

(1,894)

(3,106)

14

(3,092)

Share option scheme compensation expense granted during the period

-

-

-

1,522

-

1,522

-

1,522

Exercise of share options

2

41

-

(43)

-

-

-

-

Balance at 31 December 2013

16,462

162,939

220

3,009

(42,413)

140,217

729

140,946

 

 

Condensed consolidated cash flow statement for the period ended 31 December 2014

Unaudited 6 months ended

31 December

31 December

2014

2013

USD'000

USD'000

CASH FLOWS FOR OPERATING ACTIVITIES

Loss before taxation

(4,372)

(2,359)

Adjustments for:-

Amortisation of deferred income

(49)

(21)

Amortisation of prepaid land lease payments

73

70

Depreciation of property, plant and equipment

2,893

2,927

Interest expense

3,768

4,537

Interest income

(12)

(180)

Share based payments

2,570

1,522

Amortisation of intangible assets

113

40

Inventories written off

12

4

Intangible assets written off

47

-

Unrealised exchange loss/(gain)

1,922

(1,250)

Share of loss in joint ventures

516

532

Operating cash flow before working capital changes

7,481

5,822

Increase in inventories

(10,044)

(4,038)

(Increase)/decrease in trade and other receivables

(355)

1,428

Decrease in trade and other payables

(1,930)

(5,205)

NET CASH FOR OPERATIONS

(4,848)

(1,993)

Interest received

12

180

Interest paid

(3,768)

(4,537)

Tax refund/(paid)

101

(121)

NET CASH FOR OPERATING ACTIVITIES

(8,503)

(6,471)

CASH FLOWS FOR INVESTING ACTIVITIES

Addition of intangible assets

(1,964)

(2,708)

Addition of leasehold land

(50)

-

Addition of property, plant and equipment

(1,411)

(3,436)

Proceeds from disposal of property, plant and equipment

1

-

Investment in joint venture

(342)

(336)

NET CASH FOR INVESTING ACTIVITIES

(3,766)

(6,480)

BALANCE CARRIED FORWARD

(12,269)

(12,951)

 

 

 

 

 

 

 

Condensed consolidated cash flow statement for the period ended 31 December 2014 (continued)

Unaudited 6 months ended

31 December

31 December

2014

2013

USD'000

USD'000

BALANCE BROUGHT FORWARD

(12,269)

(12,951)

CASH FLOWS FOR FINANCING ACTIVITIES

Placement of shares

43,463

-

Drawdown of borrowings

105,101

17,066

Repayment of borrowings

(123,047)

(22,194)

Net repayment of hire purchase

(19)

(19)

Decrease/(increase) in restricted cash

7,589

(36)

NET CASH FROM/(FOR) FINANCING ACTIVITIES

33,087

(5,183)

Effects of foreign exchange rate changes on

cash and cash equivalents

(769)

(232)

CASH AND CASH EQUIVALENTS

AT BEGINNING OF THE FINANCIAL PERIOD

38,014

46,605

CASH AND CASH EQUIVALENTS AT END OF THE

FINANCIAL PERIOD

58,063

28,239

GROSS CASH

58,325

30,589

LESS: RESTRICTED CASH

(262)

(2,350)

CASH AND CASH EQUIVALENTS

58,063

28,239

 

 

 

 

 

Notes to interim financial statements

1. General information

 

The Company was incorporated and registered as a private limited company in Bermuda, under the Companies (Bermuda) Law 1991 (as amended). The Company has its primary listing on the AIM market operated by the London Stock Exchange, plc (AIM).

 

The Company is engaged principally in the business of investment holding whilst the principal activities of the rest of the Group are the production, marketing and distribution of natural sweeteners and flavours.

The unaudited condensed consolidated interim financial statements have been authorised for issue by the Board of Directors on 16 March 2015.

 

 

2. Basis of preparation

 

The condensed consolidated interim financial statements for the six months ended 31 December 2014 have been prepared in accordance with IAS 34, "Interim financial reporting". In preparing these condensed interim financial statements, the significant judgments and estimates made by management in applying the Group's accounting policies were the same as those that applied to the consolidated financial statements for the year ended 30 June 2014. The condensed consolidated interim financial statements should be read in conjunction with the Group's annual financial statements for the year ended 30 June 2014 ("FY2014"), which have been prepared in accordance with IFRSs.

 

 

3. Accounting policies

The accounting policies adopted for 1H FY2015 are as stated in the Group's FY2014 financial statements, with the addition of new standards and amendments to standards that are mandatory for the financial year beginning 1 July 2014, the new standards are summarised below:

(i) Financial year beginning on/after 1 July 2014

 

· Amendment to IAS 32, 'Financial Instruments: Presentation' does not change the current offsetting model in IAS 32. It clarifies the meaning of 'currently has a legally enforceable right of set-off' that the right of set-off must be available today (not contingent on a future event) and legally enforceable for all counterparties in the normal course of business. It clarifies that some gross settlement mechanisms with features that are effectively equivalent to net settlement will satisfy the IAS 32 offsetting criteria.

 

· Amendments to IFRS 10, IFRS 12 and IAS 27 introduce an exception to consolidation for investment entities. Investment entities are entities whose business purpose is to invest funds solely for returns from capital appreciation, investment income or both and evaluate the performance of its investments on fair value basis. The amendments require investment entities to measure particular subsidiaries at fair value instead of consolidating them.

 

· Amendment to IFRS 2 'Share-based Payment' clarifies the definition of 'vesting conditions' by separately defining 'performance condition' and 'service condition' to ensure consistent classification of conditions attached to a share-based payment.

 

 

 

 

Notes to interim financial statements (continued)

 

4. Accounting policies (continued)

The accounting policies adopted for 1H FY2015 are as stated in the Group's FY2014 financial statements, with the addition of new standards and amendments to standards that are mandatory for the financial year beginning 1 July 2014, the new standards are summarised below (continued):

(i) Financial year beginning on/after 1 July 2014 (continued)

 

· Amendment to IFRS 8 "Operating Segments" requires disclosure of the judgements made by management in aggregating operating segments. This includes a description of the segments which have been aggregated and the economic indicators which have been assessed in determining that the aggregated segments share similar economic characteristics.

 

The standard is further amended to require a reconciliation of segment assets to the entity's assets when segment assets are reported.

· Amendment to IFRS 13 "Fair Value Measurement" relates to the Basis for Conclusions which is not an integral part of the Standard. The Basis for Conclusions clarifies that when International Accounting Standards Board (IASB) issued IFRS 13, it did not remove the practical ability to measure short-term receivables and payables with no stated interest rate at invoice amounts without discounting, if the effect of discounting is immaterial.

 

· Amendment to IAS 24 "Related Party Disclosures" extends the definition of 'related party' to include an entity, or any member of a group of which it is a part, that provides key management personnel services to the reporting entity or to the parent of the reporting entity. 

The adoption of the above standards and interpretations does not have any material impact on the interim financial statements in the period of initial application.

 

 

5. Fair value estimation

 

Assets and liabilities measured at fair value can be determined based on valuation methods as defined in the fair value measurement hierarchy as follows:

(i) Quoted prices (unadjusted) in active markets for identical assets or liabilities (Level 1).

(ii) Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly (that is, as prices) or indirectly (that is, derived from prices) (Level 2).

(iii) Inputs for the asset or liability that are not based on observable market data (that is, unobservable inputs) (Level 3).

 

The Group's biological assets are measured at fair value less cost to sell and classified as Level 3 of which valuation inputs are not based on observable market data as management considers that the costs of the biological assets approximate fair value as little biological transformation has taken place since initial cost incurrences, and expect that the impact of the biological transformation on price is not expected to be material.

 

There are no other assets and liabilities of the Group which are measured at fair value. The carrying values of the financial assets and liabilities of the Group at the balance sheet date approximated their fair values.

Notes to interim financial statements (continued)

 

6. Other income

 

Other income represents net foreign exchange gain and other miscellaneous income.

 

 

7. Other expenses

 

Other expenses represent net foreign exchange loss and other operating expenses.

 

 

8. Principal risks and uncertainties

 

The Group set out in its FY2014 Annual Report and Financial Statements the financial risks including foreign currency risk, interest rate risk, credit risk, liquidity and cash flow risks and capital risk management that could impact its performance; these remain unchanged since the Annual Report was published. The Group operates a structured risk management process, which identifies and evaluates risks and uncertainties and reviews mitigation activity.

 

 

9. Seasonality

 

At 31 December 2014 the Group had gross cash of USD58 million (30 June 2014: USD46 million) and net debt of USD52 million (30 June 2014: USD80 million). Net debt is defined as short-term and long-term borrowings less cash and bank balances. The Group's sales are seasonally weighted towards the H2 of each year and net debt is expected to reduce over time as sales increase and then convert to cash. At 31 December 2014, the Group had more than USD76 million cash and banking facilities headroom. The Directors believe the banking facilities to be sufficient for projected funding requirements.

 

 

10. Segmental information

 

Management determines the Group's operating segments based on the criteria used by the Chief Operating Decision Maker who has been identified as the Chief Executive Officer (CEO) for making strategic decisions. Management considers the Group to be a single operating segment whose activities are the production, marketing and distribution of natural sweeteners and flavors.

 

From a geographical perspective, the Group is a multinational with operations located on all continents, but managed as one unified global organization.

 

Notes to interim financial statements (continued)

 

 

10. Segmental information (Cont'd)

 

31 December

31 December

2014

2013

USD'000

USD'000

Revenue

43,228

34,851

Cost of sales

(28,735)

(22,596)

Gross profit

14,493

12,255

Other income

160

305

Administrative expenses

(11,156)

(9,665)

Operating profit

3,497

2,895

Other expenses

(2,811)

(2,242)

Foreign exchange (loss)/gain

(1,074)

2,057

Finance costs

(3,768)

(4,537)

Share of loss in joint ventures

(216)

(532)

Taxation

3,445

470

Loss for the financial period

(927)

(1,889)

EBITDA

6,393

5,175

Reconciliation of Adjusted EBITDA to loss for the financial year

EBITDA

6,393

5,175

Share based payment

(2,570)

(1,522)

Others

(246)

(500)

Foreign exchange (loss)/gain

(1,074)

2,057

Finance costs

(3,768)

(4,537)

Taxation

3,445

470

Non-controlling interest

(28)

5

Depreciation and amortisation

(3,079)

(3,037)

Loss for the financial period

(927)

(1,889)

 

Under segmental reporting, share of loss in joint venture includes Group's realised profit amounting to USD 0.3 million, arising from its sales to the joint ventures. Under the statement of comprehensive income, the profit is included within the gross profit line.

Notes to interim financial statements (continued)

 

 

10. Segmental information (Cont'd)

 

31 December

31 December

2014

2013

Cash Flow

USD'000

USD'000

Operating cash flow before working capital changes

7,481

5,822

Increase in inventories

(10,044)

(4,038)

(Increase)/decrease in receivables

(355)

1,428

Decrease in payables

(1,930)

(5,205)

Net cash for operations

(4,848)

(1,993)

Net cash from/(for) financing activities

33,087

(5,183)

Gross cash at end of the financial period

58,325

30,589

31 December

30 June

2014

2014

Statement of Financial Position

USD'000

USD'000

Property, plant and equipment

59,651

63,715

Inventories

96,810

86,519

Third party trade receivables

26,091

29,107

Trade receivables from jointly controlled entities

10,129

10,205

Cash and bank balances

58,325

45,865

Total assets

314,844

292,791

Borrowings

109,803

125,850

Net debt

51,478

79,985

 

 

 

Geographical information

 

Bermuda

Asia

Europe

Americas

Goodwill

Total

USD'000

USD'000

USD'000

USD'000

USD'000

USD'000

31 December 2014

Sales

-

9,622

4,851

28,755

-

43,228

Non-current assets

725

98,092

2,007

12,811

1,806

115,441

31 December 2013

Sales

-

7,879

3,144

23,828

-

34,851

Non-current assets

1,577

100,894

1,624

11,601

1,806

117,502

 

 

The primary performance indicators used by the Group are revenues, gross profit, EBITDA, net cash from operations and net debt.

 

 

 

Notes to interim financial statements (continued)

 

 

10. Segmental information (Cont'd)

 

EBITDA is calculated as EBITDA adjusted to exclude discretionary items such as share based, bonus, foreign exchange gain/losses and any other non-recurring expenses.

 

The entity is domiciled in Bermuda. The entity's non-current assets are located in countries other than Bermuda. There is no revenue from Bermuda.

 

11. Property, plant and equipment and intangible assets

 

During the period, the Group invested USD1.4 million in property, plant and equipment.

 

The addition to intangible assets is in respect of capitalisation of project developments during the period, net of amortisation for products now launched commercially.

 

12. Inventories

 

31 December

30 June

2014

2014

USD'000

USD'000

Raw materials

14,343

14,422

Work-in-progress

18,030

11,898

Finished goods

64,437

60,199

96,810

86,519

 

 

13. Biological assets

 

As at 31 December 2014, total biological assets of USD 3.9 million (30 June 2014: USD 4.2 million) represent 5.4 million nursery plants (30 June 2014: 5.2 million). Nursery plants are carried at cost as it is deemed to have limited biological transformation. Seedlings from nursery plants are sold to farmers upon harvest and are carried at a consistent unit cost.

 

Notes to interim financial statements (continued)

 

 

14. Borrowings

 

31 December

30 June

2014

2014

USD'000

USD'000

Current

- Hire purchase

20

32

- Term loans

42,268

123,649

42,288

123,681

Non-Current

- Hire purchase

25

36

- Term loans

67,490

2,133

67,515

2,169

Total borrowings

109,803

125,850

 

 

During the period, the Group repaid bank loan amounting to USD123 million, in line with previously disclosed repayment terms. The Group then drew down bank loans amounting to USD105 million at a weighted average effective interest rate of 5% per annum. The proceeds were used to meet working capital.

 

 

15. Income taxes

Income tax expense is recognised based on management's best estimate of the weighted average annual income tax rate expected for the full financial year. The Group has no estimated assessable profit.

 

The Company was granted a tax assurance certificate dated 18 August 2007 under the Exempted Undertakings Tax Protection Act 1966 pursuant to which it is exempted from any Bermuda taxes (other than local property taxes) until 28 March 2016 which was extended to 31 March 2035 following the enactment of the Exempted Undertakings Tax Protection Amendment Act 2011.

 

A subsidiary of the Group, PureCircle Sdn Bhd (PCSB), has been granted the Bio-Nexus Status by the Malaysian Biotechnology Corporation Sdn Bhd in which PCSB is entitled to a 100% income tax exemption for a period of 10 years on its first statutory income commencing in 2009. Upon the expiry of the 10-year incentive period, PCSB will be entitled to a concessionary tax rate of 20% on income derived from qualifying activities for a further period of 10 years.

 

Another subsidiary of the Group, PureCircle (Jiangxi) Co. Ltd. (PCJX), has also been granted a 10% exemption on corporate tax from 1 January 2013 to 31 December 2020 by Ganzhou State Tax Revenue Department under the Western Ganzhou State Development program.

Notes to interim financial statements (continued)

 

 

16. Share capital and share premium

 

Number of shares

Ordinary shares

Share premium

Total

'000

USD'000

USD'000

USD'000

Balance at 1 July 2014

164,722

16,472

163,240

179,712

Issuance of shares

5,000

500

42,963

43,463

Exercise of share options

6

1

48

49

Balance at 31 December 2014

169,728

16,973

206,251

223,224

Balance at 1 July 2013

164,602

16,460

162,898

179,358

Exercise of share options

12

2

41

43

Balance at 31 December 2013

164,614

16,462

162,939

179,401

 

 

In November 2014, the Group completed a placement of 5 million new ordinary shares at GBP5.50 per share. The placement raised USD43.5 million in cash, net of expenses.

 

17. Earnings per share

 

The basic earnings per share is calculated by dividing the loss attributable to owners of the Company by the weighted average number of ordinary shares in issue during the period.

6 months ended

31 December

31 December

2014

2013

Loss attributable to equity holders of the Company (USD'000)

(899)

(1,894)

Weighted average number of ordinary shares in issue ('000)

166,041

164,616

Basic loss per share (US Cents)

(0.54)

(1.15)

 

Diluted earnings per share is not applicable as the potential ordinary shares under the Company's Long Term Incentive Plan would have an anti-dilutive effect.

 

18. Dividends

 

No dividends were declared or paid by the Company during the interim period.

 

 

19. Contingent liabilities and capital commitments

 

At the end of the period, there are no material contingent liabilities which, upon becoming enforceable, may have a material impact on the financial position of the Group.

 

Capital commitments amounting to approximately USD1.1million is approved and contracted for, these are incurred for the purchase of land and upgrading of plant and machinery in Malaysia.

 

Subsequent to the period, the Group approved an expansion capital expenditure of USD7.8 million.

Notes to interim financial statements (continued)

 

 

20. Events after the end of the reporting period

 

There were no events that had a material impact to the condensed consolidated interim financial statements after the end of the reporting period.

 

Please refer to note 19 relating to post balance sheet capital expenditure expansion.

 

21. Significant related party transactions

 

(a) Identities of related parties:

The Group and / or the Company have related party relationships with:

(i) its subsidiaries and joint ventures;

(ii) the directors who are the key management personnel; and

(iii) companies in which certain directors are common directors and / or substantial shareholders.

 

The following transactions were carried out by the Group during the period:

 

(b) Related parties

(i) Related Parties

31 December

31 December

2014

2013

USD'000

USD'000

Sales of goods to jointly controlled entities

2,885

2,536

 

(ii) Key Management Personnel

 

Key management includes executive and non-executive directors. The compensation paid or payable to key management for employee services is shown as below:

 

31 December

31 December

2014

2013

USD'000

USD'000

Paul Selway-Swift

84

44

Magomet Malsagov

279

165

John Robert Slosar

-

21

Olivier Phillipe Marie Maes

42

23

Peter Lai Hock Meng

45

26

Christopher Pratt

34

-

William Mitchell

192

166

676

445

31 December

31 December

2014

2013

USD'000

USD'000

Remuneration

676

445

 

Notes to interim financial statements (continued)

 

 

21. Significant related party transactions (continued)

 

(b) Related parties (Cont'd)

 

(ii) Key Management Personnel (Cont'd)

 

Number of Ordinary Shares Of USD0.10 Each

At

At

The Company

1 July

Bought

Sold

31 December

2014

2014

Direct Interests

Paul Selway-Swift

202,300

5,500

-

207,800

Magomet Malsagov

14,855,612

11,300

-

14,866,912

Christopher Pratt

686,916

5,500

-

692,416

Olivier Phillipe Marie Maes

408,210

10,100

-

418,310

Peter Lai Hock Meng

191,400

8,700

-

200,100

William Mitchell

910,890

13,650

-

924,540

 

 

 

Number of Options over Ordinary Shares Of USD0.10 Each

At

At

The Company

1 July

Award

Exercise

31 December

2014

2014

Direct Interests

Magomet Malsagov

686,640

5,336

-

691,976

Christopher Pratt

-

3,280

-

3,280

Olivier Phillipe Marie Maes

2,900

4,110

(2,900)

4,110

Peter Lai Hock Meng

3,200

4,360

(3,200)

4,360

William Mitchell

529,170

4,689

-

533,859

 

 

Independent review report to PureCircle Limited

 

 

PureCircle Limited

(Incorporated in Bermuda)

Registration No.: 40431

 

 

Introduction

 

We have been engaged by the Company to review the condensed consolidated interim financial statements for the six months ended 31 December 2014 set out on pages 4 to 19, which comprise the consolidated statement of comprehensive income, consolidated statement of financial position, consolidated statement of changes in equity, consolidated statement of cash flows and related notes.

 

Directors' responsibilities

 

The condensed consolidated interim financial statements are the responsibility of, and have been approved by, the directors of PureCircle Limited. The directors are responsible for preparing the condensed consolidated interim financial statements in accordance with the AIM Rules for Companies which require that the financial information must be presented and prepared in a form consistent with that which will be adopted in the Company's annual financial statements.

 

As disclosed in Note 2, the annual financial statements of the group are prepared in accordance with International Financial Reporting Standards. The condensed consolidated interim financial statements have been prepared in accordance with International Accounting Standard 34, "Interim Financial Reporting" ("IAS 34").

 

The maintenance and integrity of the PureCircle Limited website is the responsibility of the directors; the work carried out by the auditors does not involve consideration of these matters and, accordingly, the auditors accept no responsibility for any changes that may have occurred to the condensed consolidated interim financial statements since they were initially presented on the website.

 

Our responsibility

 

Our responsibility is to express to the Company a conclusion on the condensed consolidated interim financial statements based on our review. This report, including the conclusion, has been prepared for and only for the Company for the purpose of preparing the condensed consolidated interim financial statements under IAS 34 and for no other purpose. We do not, in producing this report, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing.

 

 

 

Independent review report to PureCircle Limited (continued)

 

 

PureCircle Limited

(Incorporated in Bermuda)

Registration No.: 40431

 

 

Scope of review

 

We conducted our review in accordance with International Standard on Review Engagements 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity'. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

 

Conclusion

 

Based on our review, nothing has come to our attention that causes us to believe that the condensed consolidated interim financial statements for the six months ended on 31 December 2014 are not prepared, in all material respects, in accordance with IAS 34.

 

 

 

 

 

PricewaterhouseCoopers

(No. AF: 1146)

Chartered Accountants

Kuala Lumpur

Malaysia

16 March 2015

Corporate Information

 

BOARD OF DIRECTORS

 

Non-executive Chairman

Paul Selway-Swift

 

Executive Directors

Magomet Malsagov, Chief Executive

William Mitchell, Chief Financial Officer

 

Non-executive Directors

Peter Lai Hock Meng

Olivier Maes

Christopher Pratt

 

Audit Committee

Peter Lai Hock Meng (Chairman)

Olivier Maes

Christopher Pratt

 

Remuneration Committee

Olivier Maes (Chairman)

Paul Selway-Swift

Christopher Pratt

 

Nomination Committee

Paul Selway-Swift (Chairman)

Magomet Malsagov

Olivier Maes

 

NOMINATED ADVISERS

 

RFC Ambrian Limited

Level 14, 19-31 Pitt Street

Sydney NSW 2000

Australia.

 

Level 28, QV1 Building

250 St George's Terrace

Perth WA 6000

Australia.

 

 

 

CORPORATE BROKERS

 

Macquarie Capital (Europe) LimitedRopemaker Place28 Ropemaker StreetLondon EC2Y 9HD

United Kingdom

 

Mirabaud Securities Limited

33 Grosvenor Place

London SW1X 7HY

United Kingdom

 

Liberum Capital Limited

Ropemaker Place, Level 1225 Ropemaker Street

London EC2Y 9LY

United Kingdom

 

AUDITORS

 

PricewaterhouseCoopers

Chartered Accountants

Level 10, 1 Sentral

Jalan Travers, Kuala Lumpur Sentral

PO Box 10192

50706 Kuala Lumpur

Malaysia

Shareholder Information

 

INTERNET

 

Investors and corporate stakeholders www.purecircle.com

Consumers

www.steviapurecircle.com

Health professionals, customers, policy makers, consumers

www.globalsteviainstitute.com

 

REGISTERED OFFICE

 

Clarendon House

2 Church Street

Hamilton HM 11

Bermuda

 

CORPORATE HEADQUARTERS MALAYSIA

 

10th Floor, West Wing

Rohas Perkasa

No. 9 Jalan P. Ramlee

50250 Kuala Lumpur, Malaysia

T +606 2166 2206

F +606 2166 2207

E info@purecircle.com

 

INVESTOR RELATIONS

 

Request for further copies of the annual report or other investor relation matters should be addressed to PureCircle office

 

 

 

SHARE REGISTRAR

 

In Jersey (Shares)

Computershare Investor

Services (Jersey) Limited

Queensway House, Hilgrove Street

St Helier, Jersey

JE1 1ES

Channel Islands

 

 

In the UK (Depositary Interests)

Computershare Investor Services plc

The Pavilions, Bridgwater Road

Bristol BS13 8AE, United Kingdom

 

ANNUAL GENERAL MEETING

 

The Annual General Meeting (AGM) will be announced following publication of the Group's results for financial year 2015.

 

2015 financial year and corporate calendar

Half year end 31 December 2014

Year end 30 June 2015

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR SFISDMFISEID
Date   Source Headline
1st Jul 20205:10 pmRNSScheme of Arrangement becomes Effective
30th Jun 20206:00 pmRNSNew External Auditor Appointment
29th Jun 20205:45 pmRNSChanges in the Board Composition
26th Jun 20206:37 pmRNSCourt sanction of the Scheme
18th Jun 20205:47 pmRNSResults of Court Meeting and General Meeting
18th May 20205:45 pmRNSPublication of Scheme Document
7th May 20209:37 amRNSResults of Adjourned 2019 Annual General Meeting
7th May 20207:00 amRNSDispatch Date for Scheme Document
5th May 20202:31 pmRNSPDMR Notification
1st May 20207:00 amRNSBlock Listing Application
29th Apr 20207:00 amRNSNew Banking Facility
28th Apr 20203:22 pmRNSUpdate on Adjourned 2019 Annual General Meeting
20th Apr 20209:04 amRNSForm 8.3 - PureCircle Limited
20th Apr 20208:50 amRNSForm 8.3 - PureCircle Limited
20th Apr 20208:32 amRNSForm 8 (OPD) (PureCircle Limited)
16th Apr 20203:54 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20203:08 pmRNSForm 8 (OPD) (PureCircle Limited)
16th Apr 20202:43 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20202:40 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20202:35 pmRNSForm 8.3 - PureCircle Limited
16th Apr 20202:30 pmRNSForm 8.3 - PureCircle Limited
15th Apr 20207:30 amRNSRestoration PureCircle Limited
9th Apr 20204:52 pmRNSNotice of Adjourned AGM and Annual Report
9th Apr 20202:07 pmRNSOffer for PureCircle Limited
9th Apr 20201:56 pmRNSUnaudited Interim Results and Trading Update
5th Mar 20207:00 amRNSCompany Update
5th Mar 20207:00 amRNSManagement Changes
19th Feb 20207:00 amRNSUpdate on lending facilities
10th Feb 20201:25 pmRNSResults of AGM and Directorate Change
4th Feb 20202:46 pmRNSCFO appointment effective
28th Jan 20203:45 pmRNSManagement Update
14th Jan 20204:42 pmRNSNotice of AGM and Company Update
3rd Jan 20202:00 pmRNSAppointment of CFO
2nd Jan 20207:00 amRNSBlock Listing Six Monthly Return
31st Dec 201912:15 pmRNSBoard Changes
27th Dec 20192:50 pmRNSManagement and Board Committee Changes
12th Dec 20192:40 pmRNSBoard and Management Changes
22nd Nov 20193:38 pmRNSResignation of a Director
20th Nov 20197:52 amRNSCorrection: Appointment of Directors
18th Nov 20193:42 pmRNSAppointment of Directors
14th Nov 20197:40 amRNSCompany Update
12th Nov 20192:52 pmRNSResignation of Director
28th Oct 20197:48 amRNSSuspension of share listing
25th Oct 20195:23 pmRNSPostponement of results and suspension of listing
23rd Oct 20194:35 pmRNSPrice Monitoring Extension
20th Sep 20194:40 pmRNSSecond Price Monitoring Extn
20th Sep 20194:35 pmRNSPrice Monitoring Extension
20th Sep 20194:15 pmRNSPostponement of Results
22nd Aug 20194:35 pmRNSPrice Monitoring Extension
16th Aug 20197:00 amRNSNotice of Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.